Correlation Between Capricor Therapeutics and Freeline Therapeutics

Can any of the company-specific risk be diversified away by investing in both Capricor Therapeutics and Freeline Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capricor Therapeutics and Freeline Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Capricor Therapeutics and Freeline Therapeutics Holdings, you can compare the effects of market volatilities on Capricor Therapeutics and Freeline Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capricor Therapeutics with a short position of Freeline Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capricor Therapeutics and Freeline Therapeutics.

Diversification Opportunities for Capricor Therapeutics and Freeline Therapeutics

-0.88

Correlation Coefficient

Capricor Therapeutics  Freeline Therapeutics

Pay attention - limited upside

The 3 months correlation between Capricor and Freeline is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding Capricor Therapeutics and Freeline Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Freeline Therapeutics and Capricor Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capricor Therapeutics are associated (or correlated) with Freeline Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Freeline Therapeutics has no effect on the direction of Capricor Therapeutics i.e., Capricor Therapeutics and Freeline Therapeutics go up and down completely randomly.

Pair Corralation between Capricor Therapeutics and Freeline Therapeutics

Given the investment horizon of 90 days Capricor Therapeutics is expected to generate 0.74 times more return on investment than Freeline Therapeutics. However, Capricor Therapeutics is 1.36 times less risky than Freeline Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Freeline Therapeutics Holdings is currently generating about -0.01 per unit of risk. If you would invest  350.00  in Capricor Therapeutics on September 18, 2024 and sell it today you would earn a total of  1,038  from holding Capricor Therapeutics or generate 296.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	28.89%
Values	Daily Returns

Capricor Therapeutics  vs.  Freeline Therapeutics Holdings

Capricor Therapeutics

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Capricor Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Capricor Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Freeline Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Freeline Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Freeline Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Capricor Therapeutics and Freeline Therapeutics

The main advantage of trading using opposite Capricor Therapeutics and Freeline Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capricor Therapeutics position performs unexpectedly, Freeline Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Freeline Therapeutics will offset losses from the drop in Freeline Therapeutics' long position.

The idea behind Capricor Therapeutics and Freeline Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.